» Articles » PMID: 27138039

Immunoregulatory Mechanisms in Chagas Disease: Modulation of Apoptosis in T-cell Mediated Immune Responses

Abstract

Background: Chronic Chagas disease presents different clinical manifestations ranging from asymptomatic (namely indeterminate) to severe cardiac and/or digestive. Previous results have shown that the immune response plays an important role, although no all mechanisms are understood. Immunoregulatory mechanisms such as apoptosis are important for the control of Chagas disease, possibly affecting the morbidity in chronic clinical forms. Apoptosis has been suggested to be an important mechanism of cellular response during T. cruzi infection. We aimed to further understand the putative role of apoptosis in Chagas disease and its relation to the clinical forms of the disease.

Methods: Apoptosis of lymphocytes, under antigenic stimuli (soluble T. cruzi antigens - TcAg) where compared to that of non-stimulated cells. Apoptosis was evaluated using the expression of annexin and caspase 3(+) by T cells and the percentage of cells positive evaluated by flow cytometry. In addition activation and T cell markers were used for the identification of TCD4(+) and TCD8(+) subpopulations. The presence of intracellular and plasma cytokines were also evaluated. Analysis of the activation status of the peripheral blood cells showed that patients with Chagas disease presented higher levels of activation determined by the expression of activation markers, after TcAg stimulation. PCR array were used to evaluate the contribution of this mechanism in specific cell populations from patients with different clinical forms of human Chagas disease.

Results: Our results showed a reduced proliferative response associated a high expression of T CD4(+)CD62L(-) cells in CARD patients when compared with IND group and NI individuals. We also observed that both groups of patients presented a significant increase of CD4(+) and CD8(+) T cell subsets in undergoing apoptosis after in vitro stimulation with T. cruzi antigens. In CARD patients, both CD4(+) and CD8(+) T cells expressing TNF-α were highly susceptible to undergo apoptosis after in vitro stimulation. Interestingly, the in vitro TcAg stimulation increased considerably the expression of cell death TNF/TNFR superfamily and Caspase family receptors genes in CARD patients.

Conclusions: Taken together, our results suggest that apoptosis may be an important mechanism for the control of morbidity in T. cruzi infection by modulating the expression of apoptosis genes, the cytokine environment and/or killing of effector cells.

Citing Articles

Cardiac involvement in Chagas disease and African trypanosomiasis.

Sabino E, Nunes M, Blum J, Molina I, Ribeiro A Nat Rev Cardiol. 2024; 21(12):865-879.

PMID: 39009679 DOI: 10.1038/s41569-024-01057-3.


Immunopathogenesis in infection: a role for suppressed macrophages and apoptotic cells.

Vellozo N, Matos-Silva T, Lopes M Front Immunol. 2023; 14:1244071.

PMID: 37662946 PMC: 10469960. DOI: 10.3389/fimmu.2023.1244071.


Risk Factors for Progression to Chronic Chagas Cardiomyopathy: A Systematic Review and Meta-Analysis.

Cutshaw M, Sciaudone M, Bowman N Am J Trop Med Hyg. 2023; 108(4):791-800.

PMID: 36848894 PMC: 10076993. DOI: 10.4269/ajtmh.22-0630.


Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy.

Pinto B, Medeiros N, Teixeira-Carvalho A, Fiuza J, Eloi-Santos S, Nunes M Front Cardiovasc Med. 2022; 9:750876.

PMID: 35665256 PMC: 9162138. DOI: 10.3389/fcvm.2022.750876.


Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease.

Pedra-Rezende Y, Barbosa J, Bombaca A, Dantas-Pereira L, Gibaldi D, Vilar-Pereira G Front Immunol. 2021; 12:712034.

PMID: 34804007 PMC: 8599157. DOI: 10.3389/fimmu.2021.712034.


References
1.
Mosca W, Briceno L, Hernandez M . Cell mediated immunity in Chagas' disease. Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells. Mem Inst Oswaldo Cruz. 1991; 86(2):147-52. DOI: 10.1590/s0074-02761991000200002. View

2.
Rocha M, Ribeiro A, Teixeira M . Clinical management of chronic Chagas cardiomyopathy. Front Biosci. 2002; 8:e44-54. DOI: 10.2741/926. View

3.
Rodrigues Jr V, Agrelli G, Leon S, Teixeira D, Tostes Jr S, Rocha-Rodrigues D . Fas/Fas-L expression, apoptosis and low proliferative response are associated with heart failure in patients with chronic Chagas' disease. Microbes Infect. 2007; 10(1):29-37. DOI: 10.1016/j.micinf.2007.09.015. View

4.
Gomes J, Bahia-Oliveira L, Rocha M, Busek S, Teixeira M, Silva J . Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun. 2005; 73(12):7960-6. PMC: 1307097. DOI: 10.1128/IAI.73.12.7960-7966.2005. View

5.
Zhang J, Andrade Z, Yu Z, Andrade S, Takeda K, Sadirgursky M . Apoptosis in a canine model of acute Chagasic myocarditis. J Mol Cell Cardiol. 1999; 31(3):581-96. DOI: 10.1006/jmcc.1998.0893. View